| Date | Time | Source | Headline | Symbol | Company |
| 11/03/2011 | 7:04AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/03/2011 | 7:00AM | Business Wire | Allos Therapeutics Reports Third Quarter 2011 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/26/2011 | 10:53AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/25/2011 | 4:14AM | Zacks | Zacks #1 Rank Additions for Tuesday - Tale of the Tape | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/24/2011 | 5:21PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/24/2011 | 11:00AM | Zacks | AMAG/Allos Deal Called Off - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/21/2011 | 9:27AM | Business Wire | Allos Therapeutics Announces Termination of Merger Agreement with AMAG Pharmaceuticals | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/14/2011 | 6:02AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/14/2011 | 6:02AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/13/2011 | 7:41PM | Business Wire | Allos Therapeutics Announces Settlement with Putative Class Action Plaintiffs Regarding Merger with AMAG Pharmaceuticals | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/13/2011 | 8:16AM | Marketwired | Strong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay Off | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/11/2011 | 6:09AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/11/2011 | 6:06AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/10/2011 | 8:00AM | Business Wire | Allos Therapeutics Continues to Work Toward Completion of Merger with AMAG Pharmaceuticals | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/30/2011 | 5:01PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/30/2011 | 6:01AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/30/2011 | 6:01AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/23/2011 | 3:25PM | Business Wire | Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/21/2011 | 8:02AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/21/2011 | 8:00AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/21/2011 | 6:01AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/19/2011 | 8:16AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/16/2011 | 5:21PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/16/2011 | 4:13PM | Edgar (US Regulatory) | Amended Current report filing (8-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/15/2011 | 5:05PM | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (DEFM14A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/19/2011 | 4:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/19/2011 | 4:20PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/19/2011 | 4:18PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/18/2011 | 1:16PM | Zacks | Allos Therapeutics Starts Cancer Study - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/17/2011 | 8:00AM | Business Wire | Allos Therapeutics Initiates Phase 3 Registration Trial of FOLOTYN® in Newly Diagnosed Patients with Peripheral T-Cell Lymph... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |